title: Cryptococcus uniguttulatus Meningitis.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN.
authors.forename: Chinelo
authors.initials: C
authors.lastname: Animalu
authors.forename: Shirin
authors.initials: S
authors.lastname: Mazumder
authors.forename: Kerry O
authors.initials: KO
authors.lastname: Cleveland
authors.forename: Michael S
authors.initials: MS
authors.lastname: Gelfand
mesh_terms: D061605:Administration, Intravenous; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage; D003454:Cryptococcus / Q000187:drug effects / Q000302:isolation & purification; D057915:Drug Substitution; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D016919:Meningitis, Cryptococcal / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D013129:Spinal Puncture / Q000379:methods; D016896:Treatment Outcome; D065819:Voriconazole / Q000008:administration & dosage*
chemical_list: D000935:Antifungal Agents; D005938:Glucocorticoids; C068538:liposomal amphotericin B; D000666:Amphotericin B; D015725:Fluconazole; D065819:Voriconazole